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Abstract
Background: Tuberculosis (TB) remains a major cause of avoidable deaths. Economic migrants represent a vulnerable
population due to their exposure to medical and social risk factors. These factors expose them to higher risks for TB
incidence and poor treatment outcomes.
Methods: This cross-sectional study evaluated WHO-defined TB treatment outcomes among economic migrants in an
urban district of Ho Chi Minh City, Viet Nam. We measured the association of a patient’s government-defined residency
status with treatment success and loss to follow-up categories at baseline and performed a comparative interrupted
time series (ITS) analysis to assess the impact of community-based adherence support on treatment outcomes. Key
measures of interest of the ITS were the differences in step change (β6) and post-intervention trend (β7).
Results: Short-term, inter-province migrants experienced lower treatment success (aRR = 0.95 [95% CI: 0.92–0.99],
p = 0.010) and higher loss to follow-up (aOR = 1.98 [95% CI: 1.44–2.72], p < 0.001) than permanent residents. Intra-
province migrants were similarly more likely to be lost to follow-up (aOR = 1.86 [95% CI: 1.03–3.36], p = 0.041).
There was evidence that patients > 55 years of age (aRR = 0.93 [95% CI: 0.89–0.96], p < 0.001), relapse patients
(aRR = 0.89 [95% CI: 0.84–0.94], p < 0.001), and retreatment patients (aRR = 0.62 [95% CI: 0.52–0.75], p < 0.001) had
lower treatment success rates. TB/HIV co-infection was also associated with lower treatment success (aRR = 0.77
[95% CI: 0.73–0.82], p < 0.001) and higher loss to follow-up (aOR = 2.18 [95% CI: 1.55–3.06], p < 0.001). The provision of
treatment adherence support increased treatment success (IRR(β6) = 1.07 [95% CI: 1.00, 1.15], p = 0.041) and reduced
loss to follow-up (IRR(β6) = 0.17 [95% CI: 0.04, 0.69], p = 0.013) in the intervention districts. Loss to follow-up continued
to decline throughout the post-implementation period (IRR(β7) = 0.90 [95% CI: 0.83, 0.98], p = 0.019).
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Conclusions: Economic migrants, particularly those crossing provincial borders, have higher risk of poor treatment
outcomes and should be prioritized for tailored adherence support. In light of accelerating urbanization in many
regions of Asia, implementation trials are needed to inform evidence-based design of strategies for this vulnerable
population.
Keywords: Adherence, Tuberculosis, Economic migrants, Treatment outcomes, Loss to follow-up, Impact evaluation
Background
Tuberculosis (TB) is a leading cause of death worldwide.
In 2017, there were an estimated ten million incident
cases of TB worldwide and 1.3 million TB deaths. An esti-
mated 458,000 patients suffered from multidrug-resistant
TB [1]. Viet Nam ranks 15th among the 30 high-burden
countries, with 126,000 new TB patients each year, includ-
ing 8200 rifampicin-resistant patients, and 13,000 deaths
due to TB [2]. Through comprehensive implementation of
the DOTS (Directly observed treatment, short-course)
strategy, the Vietnamese National TB Control Program
(NTP) has reduced TB prevalence and mortality by an
average of 4–5% per annum [3].
In 2014, the government passed legislation to end TB
by 2030 [4]. However, this ambitious goal will require
sustained political commitment and multifactorial in-
tensification of the TB program. For people with drug-
susceptible TB, who comprise an estimated 95% of Viet
Nam’s TB burden, the minimum treatment duration is
6 months and completing the full course of treatment
can be challenging [5, 6]. Comprehensively documented
barriers to successful treatment completion include pill
burden, adverse events and the need for daily attend-
ance at treatment clinics to take DOTS [7–9]. An-
other major reason is that adherence to TB treatment
protocols represents a heavy economic burden for TB
patients in Viet Nam and many other settings due to
lost income, travel and opportunity costs [10, 11]. A
key barrier to effective TB care and prevention is loss
to follow-up (LTFU), which is a key contributor to
drug resistance, continued transmission and death
[12, 13]. Nevertheless, 77–92% of susceptible cases
were successfully treated in 2017 [2].
Socially marginalized, high-risk subgroups commonly
experience access barriers to TB care that result in poor
treatment outcomes [14]. Economic migrants, defined
as non-permanent residents in search of economic op-
portunity [15, 16], constitute a key affected population.
These migrants may face systemic barriers to housing,
education, financing and healthcare (Table 1) [17, 18].
As a result, they can suffer from a higher prevalence of
TB compared to local residents and higher rates of
treatment interruptions, poor outcomes and drug resist-
ance [19, 20]. In addition to transiency, these popula-
tions also exhibit other characteristics that have been
associated with poor treatment outcomes such as low
socioeconomic status, high-risk behaviors and comor-
bidities [21, 22].
As for many Asian countries with a high TB bur-
den, Viet Nam has undergone dramatic transform-
ation in the last two decades. This resulted in rapid
urbanization and economic migration, which may
have also affected the local TB epidemiology. A study
in Da Nang, an industrial hub in central Viet Nam,
linked young, male migrants to increased notifications
rates in urban, industrialized districts from 1999 to
2004 [23].
In the recent past, attention has been renewed in the
potential of community health worker programs to ac-
complish public health objectives [24]. Studies across
various disease areas have shown that treatment support
provided by community health workers can improve
treatment outcomes [25]. Despite heterogeneity in the
engagement models, various studies have documented
the positive influence of community-based groups on
TB treatment outcomes [26, 27].
This study took place in Ho Chi Minh City
(HCMC), one of the fastest growing cities of Viet
Nam, and a magnet for rural-to-urban, economic mi-
gration. The city’s net migration rate of 11.6% over
the past decade mirrored its average economic growth
of over 11% per annum [28]. Low-income, inter-
province migrants are estimated to settle in HCMC at
a rate of approximately 200,000 people annually [29].
Unregistered migrants may raise population figures by
15% above official estimates [30]. In this context, we
aimed to determine, if intensified treatment adherence
support provided by community health workers can
improve TB treatment outcomes in a city district with
a high density of this vulnerable population.
Methods
Study design & aims
This is a cross-sectional analysis of routine TB surveil-
lance data from Go Vap and District 8, Ho Chi Minh City,
Viet Nam. The primary aim of the study was to determine
if there is association between the government-defined
residency status and WHO-defined treatment success and
loss to follow-up. The secondary aim was to conduct a
comparative impact evaluation on these two outcomes
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after initiation of a treatment adherence intervention car-
ried out by community health workers in Go Vap. District
8 served as the concurrent control area providing only
routine government TB program services.
Study setting
Figure 1 shows the relative location of the two study dis-
tricts within Ho Chi Minh City. Go Vap district housed a
population of 685,000 people in 16 communes on an area
of 20km2. The control was District 8, which housed 450,
000 persons in 16 communes on 19km2 with a compar-
able demographic composition. Each district has one Dis-
trict TB Unit (DTU), which diagnoses TB and administers
DOTS. The provincial TB control program recommended
the intervention and control districts based on the com-
parability of their relative demographics and TB burden.
Intervention
The intervention began in April 2014 and consisted of
an intensified support program provided by incentivized
community health workers. Individuals diagnosed with
TB were contacted by the health workers within two
weeks of diagnosis and received counseling at a location
of their choice. Subsequent activities were determined
by the support workers according to their perception of
each patient’s need and included periodic in-person
visits, phone calls or text messages with frequency and
modality tailored to patient preferences and adherence
patterns. Patients who missed scheduled appointments
for directly observed therapy or follow-up sputum
tests were contacted within 48 h by phone followed
by a home visit by the community health worker, if
unreachable.
Community health workers
These activities were implemented by a cadre of 16 com-
munity health workers (CHW), who received a monthly
salary (USD168) and performance-based incentives for
case finding and treatment support. All CHWs were fe-
male with a median age of 56.5 (IQR: 54–58). The
CHWs were recruited from local sociopolitical organiza-
tions, such as the Women’s Union and Red Cross Asso-
ciation, retired public health staff, and community
health, population and family planning volunteers.
Table 1 Categorization of residents, their status, rights, obstacles and restrictions [17]
Category Status Rights Obstacles/Legal restrictions
Permanent
residents (KT1)
Residents (including both non-migrants and mi-
grants) with permanent household registration at
place of current residence
• Purchase and sell land and
housing and have land/
house ownership certificates
• Access to public facilities
and social services at
current place of residence
• Access to formal financial
loans
• Access to employment
• Access to public social services including
education and health care only within their
district of residence
Intra-province
migrants (KT2)
Migrants who have permanent household
registration in the province/city of current residence
• Purchase and sell land and
housing and have land/
house ownership
certificates.
• Access to public facilities
and social services
• Access to formal financial
loans
• Access to employment
• Access to education and health care only
within the district where they are registered
• Lack of access to financial loans/formal
financial services
Long-term,
inter-province
migrants (KT3)
Migrants who do not have permanent registration
at the place of current residence but have
temporary registration for 6–12 months with the
possibility of extension
• Access to public facilities
and social services
• Lack of access to legal housing
• KT3 children can go to public schools only
when they are not used to full capacity (by
KT1 and KT2 children). If the schools are
overcrowded, KT3 children must attend
private schools, where they have to pay
higher school fees
• Lack of access to financial loans/formal
financial services
Short-term,
inter-province
migrants (KT4)
Migrants who do not have permanent registration
at the place of current residence but have
temporary registration for 1–6 months
Do not have the right to
purchase land and access to
public social services and
financial loans
Unregistered
residents
Those who do not belong to any of the above
categories
Do not have the right to
purchase land and access to
public social services and
financial loans
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Data sources & processing
The study used digitized data from patient registers of
the NTP’s routine surveillance system. The sample con-
sisted of all drug-sensitive TB patients notified by the
Go Vap and District 8 DTUs from 1 January 2011 to 31
March 2017. The intervention commenced 31 March
2014. We excluded cases with missing data in any of the
primary exposure or outcome variables. For the primary
exposure we used Viet Nam’s official, four-tier residency
classification system: 1) permanent resident (abbreviated
KT1); 2) long-term-intra-province migrant (KT2); 3)
long-term-inter-province migrant (KT3); and 4) short-
term-inter-province migrant (KT4). Other available pa-
tient covariates from the registers were used to estimate
secondary risk factors. To assess the post-intervention
impact, we used monthly treatment success and loss to
follow-up rates aggregated by treatment initiation date.
Data analysis
All analyses were performed on Stata for Windows ver-
sion 13. Descriptive statistics for study participants were
cross-tabulated, and crude risk and odds ratios were cal-
culated for primary and secondary exposures using
univariate log-binomial and logistic regressions for treat-
ment success and loss to follow-up, respectively.
Saturated, multivariate log-binomial and logistic max-
imum likelihood models were fitted onto the data to
control for confounding and to identify pre-intervention
risk factors. For non-converging log-binomial models we
used Poisson regression with robust standard errors. We
measured associations between treatment success and
loss to follow-up rates, and individual parameters plus a
binary bifurcation of permanent and temporary (KT2-
KT4) residency for crude analyses. For multivariate ana-
lyses we used the categorical residency parameter, which
we tested for a dose-response effect, considering short-
term inter province migrants to be the most intensely
exposed to the vulnerabilities of migrant status, and
long-term intra-province migrants the least exposed.
We conducted a comparative interrupted time series
(ITS) analysis on aggregate monthly treatment success
and loss to follow-up rates using segmented log-linear
Poisson regression with robust standard errors [31]. We
modeled the ITS to include a step and a slope change.
The step change aimed to reflect the instantaneous impact
of the missed dose follow-up activities by the CHWs. The
slope change estimated the impact of increased counseling
and continuous case holding activities to cause gradual posi-
tive changes in treatment success and loss to follow-up rates.
The parameters of the ITS were obtained for a segmented
regression model with the following structure: Yt= β0+β1Tt+
β2Xt+ β3XtTt+ β4Z+ β5ZTt+ β6ZXt+ β6ZXtTt+ ϵt. Here Yt
is the outcome measure along time t; Tt is the monthly time
counter; Xt indicates pre- and post-intervention periods, Z
denotes the intervention cohort, and ZTt, ZXt, and ZXtTt are
interaction terms. β0 to β3 relate to the control group as fol-
lows: β0, intercept; β1, pre-intervention trend; β2, post-
intervention step change; β3, post-intervention trend. β4 to β7
represent differences between the control and intervention
districts: β4, difference in baseline intercepts; β5, difference in
Fig. 1 Relative location of Go Vap and District 8 in Ho Chi Minh City
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pre-intervention trends; β6, difference in post-intervention
step changes; β7, difference in post-intervention trend.
The ITS analysis was conducted in two iterations. The
first iteration included the complete sample, while the
second iteration focused on temporary residents. We in-
cluded all patients notified after 1 August 2013 in the
exposed group based on the proportion of treatment
outcomes reported in the post-intervention period. The
Cumby-Huizinga test was used to identify serial autocor-
relation in the intervention district and to adjust the ITS
analysis using the generalized estimating equation (GEE)
approach. We obtained model specifications from quasi-
likelihood information criteria. Hypothesis tests were
two-sided and point estimates included 95% confidence
intervals.
Ethical considerations
The London School of Hygiene and Tropical Medicine
Research Ethics Committee granted ethical approval for
the epidemiologic analysis. The HCMC People’s Com-
mittee approved the implementation of the intervention.
The Go Vap District Health Center approved use of the
data. A consent waiver was granted based on the study’s
use of routine surveillance data. We anonymized all pa-
tient data and removed identifying information prior to
analysis.
Results
The total sample included 10,515 drug-susceptible TB
patients notified at the Go Vap and District 8 DTUs
(Table 2), of whom 52.3% (5502/10,515) were notified
prior to the intervention. The pre-intervention sample
contained 31% (1711/5502) women and the median age
was 41 (IQR: 29–53). Permanent residents comprised
77% (4258/5502) of the sample. Among temporary resi-
dents, 14% (170/1244) were classified as intra-province
migrants, 27% (340/1244) held long-term, inter-province
migrant status and 59% (734/1244) were registered as
short-term, inter-province migrants. Treatment success
was recorded for 84% of patients (4630/5502), while 5%
(262/5502) were lost to follow-up. The overall death rate
was 4% (232/5502), but ranged from 2% (25/1244) in
temporary residents to 5% (207/4258) in permanent
residents.
While crude analysis did not detect an association be-
tween treatment success and residency (Table 3), there
was strong evidence that temporary residents (OR = 1.63
[95% CI: 1.25–2.13], p < 0.001) and particularly short-
term, inter-province migrants (OR = 2.07 [95% CI: 1.53–
2.79], p < 0.001) were more likely to be lost to follow-up
in the pre-intervention period. Adjusting for potential
confounders, short-term, inter-province migrants suf-
fered marginally lower treatment success (aRR = 0.95
[95% CI: 0.92–0.99], p = 0.010), but were at substantially
higher risk of loss to follow-up (aOR = 1.98 [95% CI:
1.44–2.72], p < 0.001) (Table 4). There was moderate
evidence that intra-province migrants were more likely
to be lost to follow-up (aOR = 1.86 [95% CI: 1.03–3.36],
p = 0.041) than permanent residents.
There was strong evidence that patients over 55 years of
age (aRR = 0.93 [95% CI: 0.89–0.96], p < 0.001), relapse pa-
tients (aRR = 0.89 [95% CI: 0.84–0.94], p < 0.001), and
retreatment patients (aRR = 0.62 [95% CI: 0.52–0.75], p <
0.001) were associated with lower treatment success. TB/
HIV patients were associated with both lower treatment
success (aRR = 0.77 [95% CI: 0.73–0.82], p < 0.001) and
higher loss to follow-up (aOR = 2.18 [95% CI: 1.55–3.06],
p < 0.001). Conversely, smear negativity (aRR = 1.06 [95%
CI: 1.03–1.09], p < 0.001) and extra-pulmonary TB (aRR =
1.05 [95% CI: 1.02–1.08], p = 0.001) were associated with
higher treatment success, while TB patients with 45–54
years of age (aOR = 0.59 [95% CI: 0.37, 0.93], p = 0.024)
and 55+ years (aOR = 0.58 [95% CI: 0.36, 0.93], p = 0.024)
were less likely to be lost to follow-up.
The time series data consisted of 150 monthly aggre-
gate counts of treatment outcomes balanced between
intervention and control districts. The median number
of monthly outcomes in both districts was 69 (IQR: 61–
78) with a median treatment success count of 59 (IQR:
52–69) and a median loss to follow-up count of 2 (IQR:
0–4). There was no statistical difference between the
intervention and control districts (Table 5 and Fig. 2) in
baseline rate (β4) and pre-intervention trend (β5) for ei-
ther outcomes of interest, i.e., treatment success (p(β4) =
0.909; p(β5) = 0.541) and loss to follow-up (p(β4) = 0.060;
p(β5) = 0.305). After implementation of the intervention
and adjusting for trends in the control area, we mea-
sured a step increase in treatment success (IRR(β6) =
1.07 [95% CI: 1.00, 1.15], p = 0.041) and a step reduction
in loss to follow-up (IRR(β6) = 0.17 [95% CI: 0.04, 0.69],
p = 0.013). We further detected evidence of a significant
trend change in the control-adjusted, post-intervention
loss to follow-up rate (IRR(β7) = 0.90 [95% CI: 0.83,
0.98], p = 0.019) in the intervention district. We did not
detect a statistical difference in post-intervention treat-
ment outcomes among temporary residents.
Discussion
Our findings suggest that under routine program condi-
tions, economic migrants in Go Vap and District 8, par-
ticularly those crossing provincial borders, suffered
poorer TB treatment outcomes. These findings are con-
cordant with past studies in other countries that evinced
greater rates of non-adherence, challenges in case man-
agement and higher rates of LTFU among economic mi-
grants [32, 33]. While most prior research dichotomized
study populations into local residents and rural-to-urban
migrants [34], we aimed to increase granularity by
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identifying the relative risks within Viet Nam’s four offi-
cial residency designations including three sub-segments
of temporary residents. While there was no clear dose-
response relationship, two of the three temporary resi-
dent subgroups indeed experienced poorer treatment
outcomes. Particularly, short-term-inter-province (KT4)
migrants – the most vulnerable subgroup of temporary
residents in terms of access to public services (Table 1)
– exhibited the highest risk and strongest statistical evi-
dence for lower treatment success and higher loss to
follow-up.
Several secondary factors were similarly strong predic-
tors of poor treatment outcomes. HIV co-infection, prior
history of TB and old age were associated with lower
Table 2 Sample characteristics of notified TB cases by residency
Total N (%) Permanent residents,
KT1 N (%)
Intra-province,
KT2 N (%)
Long-term, inter-province
KT3 N (%)
Short-term, inter-province
KT4 N (%)
Temporary residents,
KT2-KT4 N (%)
Total 5502 (100) 4258 (77) 170 (3) 340 (6) 734 (13) 1244 (23)
Sex
Male 3791 (69) 3000 (70) 107 (63) 230 (68) 454 (62) 791 (64)
Female 1711 (31) 1258 (30) 63 (37) 110 (32) 280 (38) 453 (36)
Age
< 25 years 829 (15) 529 (12) 29 (17) 62 (18) 209 (29) 300 (24)
25–34 years 1331 (24) 906 (21) 44 (26) 108 (32) 273 (37) 425 (34)
35–44 years 1123 (20) 904 (21) 33 (19) 65 (19) 121 (17) 219 (18)
45–54 years 1120 (20) 953 (22) 30 (18) 66 (19) 71 (10) 167 (13)
> 55 years 1087 (20) 955 (22) 34 (20) 39 (11) 59 (8) 132 (11)
Treatment outcome
Success 4630 (84) 3587 (85) 137 (81) 295 (87) 611 (83) 1043 (83)
Cure 2598 (47) 2032 (48) 75 (44) 172 (51) 319 (43) 566 (46)
Complete 2032 (37) 1555 (37) 62 (36) 123 (36) 292 (40) 477 (38)
LTFU 262 (5) 179 (4) 13 (8) 9 (3) 61 (8) 83 (7)
Failure 225 (4) 188 (4) 8 (5) 16 (5) 13 (2) 37 (3)
Death 232 (4) 207 (5) 5 (3) 11 (3) 9 (1) 25 (2)
Transfer out 153 (3) 97 (2) 7 (4) 9 (3) 40 (5) 56 (5)
Patient type┼
New 4301 (78) 3261 (21) 143 (84) 277 (81) 620 (84) 1040 (84)
Relapse 527 (10) 459 (11) 13 (8) 17 (5) 38 (5) 68 (5)
Failure 100 (2) 85 (2) 1 (1) 8 (2) 6 (1) 15 (1)
LTFU 55 (1) 44 (1) 2 (1) 2 (1) 7 (1) 11 (1)
Unknown 311 (6) 256 (6) 5 (3) 22 (6) 27 (4) 55 (4)
Transfer in 208 (4) 153 (4) 6 (4) 14 (4) 35 (5) 55 (4)
Type of TB§
AFB(+) 3205 (34) 2500 (59) 94 (55) 208 (61) 403 (55) 705 (57)
AFB(−) 1096 (22) 862 (20) 38 (22) 66 (19) 130 (18) 234 (19)
EP 1201 (25) 896 (21) 38 (22) 66 (19) 201 (27) 305 (25)
HIV/AIDS¶
No/Unknown 4886 (89) 3761 (88) 144 (85) 310 (91) 671 (91) 1125 (90)
Yes 616 (11) 497 (12) 26 (15) 30 (9) 63 (9) 119 (10)
Diabetes mellitus
No/Unknown 5169 (94) 3976 (93) 160 (94) 321 (94) 712 (97) 1193 (96)
Yes 333 (6) 282 (7) 10 (6) 19 (6) 22 (3) 51 (4)
Notes
┼Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain
exposure to anti-TB drugs;
§AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
¶Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;
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treatment success. These findings are concordant with
other settings [35, 36]. This result also explains the
higher death rate among permanent residents. Economic
migrants tend to be younger as their main objective for
migration is livelihood improvement [15]. This usually
excludes older and sick populations from this group and
Table 3 Crude associations of residency and secondary exposures with treatment success and loss to follow-up (n = 5502)
Treatment success Loss to follow-up
RR‡ 95% CI p-valueÞ OR‡ 95% CI p-valueÞ
Total n/a n/a n/a n/a n/a n/a
Residency
Permanent¥ 1.00 1.00
Temporary 1.00 [0.97, 1.02] 0.736 1.63 [1.25, 2.13] < 0.001
Residency
KT1¥ 1.00 1.00
KT2 0.96 [0.89, 1.03] 0.246 1.89 [1.05, 3.39] 0.033
KT3 1.03 [0.99, 1.08] 0.184 0.62 [0.31, 1.22] 0.167
KT4 0.99 [0.95, 1.02] 0.504 2.07 [1.53, 2.79] < 0.001
Sex
Male¥ 1.00 1.00
Female 1.05 [1.03, 1.08] < 0.001 0.78 [0.59, 1.04] 0.089
Age
< 25 years¥ 1.00 1.00
25–34 years 0.95 [0.91, 0.98] 0.001 1.23 [0.86, 1.78] 0.260
35–44 years 0.96 [0.92, 0.99] 0.015 0.84 [0.56, 1.26] 0.410
45–54 years 0.97 [0.94, 1.00] 0.071 0.58 [0.37, 0.91] 0.016
> 55 years 0.91 [0.87, 0.94] < 0.001 0.55 [0.35, 0.86] 0.010
Patient type┼
New¥ 1.00 1.00
Relapse 0.86 [0.82, 0.91] < 0.001 1.02 [0.66, 1.58] 0.925
Failure 0.61 [0.51, 0.73] < 0.001 1.61 [0.74, 3.52] 0.232
LTFU 0.82 [0.69, 0.97] 0.019 2.14 [0.84, 5.43] 0.109
Unknown 0.94 [0.89, 0.99] 0.018 1.39 [0.86, 2.26] 0.182
Transfer in 0.85 [2.05, 2.93] < 0.001 1.66 [0.96, 2.87] 0.067
Type of TB§
AFB(+)¥ 1.00 1.00
AFB(−) 1.09 [1.06, 1.12] < 0.001 0.78 [0.55, 1.09] 0.143
EP 1.07 [1.04, 1.10] < 0.001 0.87 [0.64, 1.20] 0.398
HIV/AIDS¶
No/Unknown¥ 1.00 1.00
Yes 0.78 [0.74, 0.83] < 0.001 2.56 [1.90, 3.46] < 0.001
Diabetes
No/Unknown¥ 1.00 1.00
Yes 0.96 [0.91, 1.01] 0.145 0.87 [0.50, 1.51] 0.622
Notes
‡Crude Risk Ratios and Odds Ratios calculated by univariate log binomial and logistic regression, respectively;
ÞWald test;
¥Referent;
┼Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain exposure to
anti-TB drugs;
§AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
¶Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;
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therefore renders the group less likely to die through-
out the course of TB treatment. In our study, smear
negative and extra-pulmonary TB patients showed a
higher likelihood of treatment success. The higher
treatment success in these patients was possibly a re-
sult of the Go Vap DTU’s decentralization strategy
for DOT. While smear positive TB patients took TB
treatment under DOT at the DTU until the end of
the intensive phase, smear negative and extra-
pulmonary patients were referred to their commune
health station immediately upon enrollment. The
shorter distances for DOT may have contributed to
higher adherence and better outcomes as observed in
other settings [37, 38].
Table 4 Adjusted associations of residency and secondary exposures with treatment success and loss to follow-up (n = 5490)
Treatment success Loss to follow-up
aRR‡ 95% CI p-valueÞ aOR‡ 95% CI p-valueÞ
Residency
KT1¥ 1.00 1.00
KT2 0.95 [0.88, 1.02] 0.163 1.86 [1.03, 3.36] 0.041
KT3 1.01 [0.97, 1.05] 0.685 0.59 [0.30, 1.17] 0.134
KT4 0.95 [0.92, 0.99] 0.010 1.98 [1.44, 2.72] < 0.001
Sex
Male¥ 1.00 1.00
Female 1.02 [1.00, 1.05] 0.078 0.80 [0.60, 1.07] 0.139
Age
< 25 years¥ 1.00 1.00
25–34 years 1.00 [0.97, 1.04] 0.881 1.00 [0.68, 1.46] 0.982
35–44 years 1.01 [0.97, 1.04] 0.622 0.73 [0.48, 1.11] 0.142
45–54 years 1.00 [0.96, 1.03] 0.863 0.59 [0.37, 0.93] 0.024
> 55 years 0.93 [0.89, 0.96] < 0.001 0.58 [0.36, 0.93] 0.024
Patient type┼
New¥ 1.00 1.00
Relapse 0.89 [0.84, 0.94] < 0.001 1.09 [0.69, 1.73] 0.705
Failure 0.62 [0.52, 0.75] < 0.001 1.77 [0.80, 3.95] 0.160
LTFU 0.87 [0.73, 1.02] 0.085 1.79 [0.69, 4.62] 0.228
Unknown 0.97 [0.92, 1.02] 0.198 1.42 [0.86, 2.36] 0.171
Transfer in 0.88 [0.81, 0.96] 0.003 1.48 [0.85, 2.60] 0.170
Type of TB§,Π
AFB(+)¥ 1.00 1.00
AFB(−) 1.06 [1.03, 1.09] < 0.001 0.79 [0.55, 1.12] 0.184
EP 1.05 [1.02, 1.08] 0.001 0.77 [0.55, 1.08] 0.126
HIV/AIDS¶
No/Unknown¥ 1.00 1.00
Yes 0.77 [0.73, 0.82] < 0.001 2.18 [1.55, 3.06] < 0.001
Diabetes
No/Unknown¥ 1.00 1.00
Yes 0.96 [0.91, 1.02] 0.159 1.15 [0.65, 2.03] 0.619
Notes
‡Adjusted summary RR and OR by log binomial and logistic regression, respectively, adjusted by all other variables listed in the table;
ÞWald test;
¥Referent;
┼Failure = Retreatment after category I treatment failure; LTFU = Retreatment after loss to follow-up; Unknown = Retreatment with unknown/uncertain exposure to
anti-TB drugs;
§AFB(+) = Sputum smear positive; AFB(−) = Sputum smear negative; EP = Extra-pulmonary TB;
Πnot included in the final convergent multivariate model with LTFU as the primary outcome
¶Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome;
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In addition to poorer treatment outcomes, economic
migrants have exhibited an elevated risk profile along
the entire TB care pathway. Economic migrants tend to
be of lower socioeconomic status, suffer from poor living
conditions and experience challenges in access to health-
care in general [39] and TB care services in particular
[40]. Access barriers contribute to patient- and provider-
initiated delays in health-seeking and in diagnosis of the
disease [41], whereby TB infection may also be more
prevalent among economic migrants [42]. With rising
urbanization, these economic migrants constitute an es-
calating risk factor to successful TB care and prevention.
In addition, studies that assessed the impact on the point
of origin of economic migrants found elevated risk of
“exported” TB among family members of these circular
migrants. This mobility and geographic reach further ex-
acerbates the complexity of TB care in this subpopula-
tion [43].
Our comparative ITS analysis was concordant with
previously reported findings that community-based
treatment support can have a substantial, positive effect
on treatment outcomes [44]. As prior evidence has
shown, the use of incentives and subsidies, and support
for side effect management can also have a significant
positive impact on TB treatment outcomes in urban mi-
grants [16, 45]. Even though our comparative ITS ana-
lysis on the subpopulation of temporary residents failed
to detect a significant change after implementation of
the intervention possibly due to data sparsity, it may be
reasonable to extend our findings to economic migrants
given their high proportion in the general population (~
38%) and TB patient cohort (23%) of Go Vap. The dis-
parity in these two proportions also reinforces the WHO
recommendation of systematic screening among mi-
grants, as studies have shown that intensified case find-
ing along with patient education, advocacy and robust
referral mechanisms can have a positive impact on de-
tection within this vulnerable group [46].
Research on TB and migration has traditionally con-
centrated on international cross-border migration, par-
ticularly from high-incidence, low-resource settings to
high-income countries [47]. Economically-motivated,
rural-to-urban migration has become an area of interest
only in recent years with rising urbanization trends. The
relative scarcity of studies on these rural-to-urban mi-
grants is possibly due to insufficiently recorded residency
status outside of countries with strong central planning
and unitary political systems, such as China and Viet
Nam, where institutionalized household registration sys-
tems (hokuo and ho khau, respectively) can facilitate
identification and segmentation of the general popula-
tion into these subgroups. However, even in the absence
of clear denomination mechanisms, studies from devel-
oped countries have shown the effectiveness of social
support in improving TB treatment outcomes among
migrants [48]. Nevertheless, more evidence is needed to
address potential barriers to economic migrants in regis-
tering residency, gaining full access to locally available
public services and overcoming the risk inequalities in
this subpopulation tied to social determinants of health.
The study presented here suffers from several limita-
tions. The data may contain measurement bias due to its
reliance on routine surveillance data and due to low
sample sizes in certain subgroups such as the monthly
number of temporary residents notified and subse-
quently lost to follow-up. The cross-sectional nature of
Table 5 Comparative interrupted time series analysis of monthly treatment success and loss to follow-up rates
Treatment success Loss to follow-up
IRR┼ 95% CI p-valueÞ IRR‡ 95% CI p-valueÞ
Baseline rate (β0)¥ 0.85 [0.83, 0.87] < 0.001 0.05 [0.03, 0.09] < 0.001
Pre-intervention trend, control (β1) 1.00 [1.00, 1.00] 0.624 0.96 [0.92, 0.99] 0.024
Post-intervention step change, control (β2) 1.00 [0.97, 1.03] 0.971 2.41 [0.97, 6.00] 0.059
Post-intervention trend, control (β3) 1.00 [1.00, 1.00] 0.382 1.04 [1.00, 1.09] 0.050
Difference in baseline (β4) 1.00 [0.95, 1.05] 0.909 1.91 [0.97, 3.76] 0.060
Difference in pre-intervention trends (β5) 1.00 [1.00, 1.00] 0.541 1.02 [0.98, 1.07] 0.305
Difference in post-intervention step change (β6) 1.07 [1.00, 1.15] 0.041 0.17 [0.04, 0.69] 0.013
Difference in post-intervention trends (β7) 1.00 [1.00, 1.00] 0.435 0.90 [0.83, 0.98] 0.019
Notes
All patients in intervention and control districts, January 2011 to March 2017
¥The parameters were obtained for a segmented regression model with the following structure: Yt = β0 + β1Tt + β2Xt + β3XtTt + β4Z + β5ZTt + β6ZXt + β6ZXtTt;+ϵt. Here
Yt is the outcome measure along time t; Tt is the monthly time counter; Xt indicates pre- and post-intervention periods, Z denotes the intervention cohort, and ZTt,
ZXt, and ZXtTt are interaction terms. β0 to β3 relate to the control group as follows: β0, intercept; β1, pre-intervention trend; β2, post-intervention step change; β3,
post-intervention trend. β4 to β7 represent differences between the control and intervention districts: β4, difference in baseline intercepts; β5, difference in pre-
intervention trends; β6, difference in post-intervention step changes; β7, difference in post-intervention trend
┼IRR based on log-linear Poisson regression with robust standard error estimations;
‡IRR based on log-linear GEE Poisson regression with an autoregressive correlation structure with lag order 2;
ÞWald test;
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the study limits the ability to infer causality and
generalizability of the results. Nevertheless, this study
may serve as an initial example of further stratification
of internal migrants for more detailed analyses, and de-
sign of bespoke interventions and policy responses.
Conclusions
Ending TB will require comprehensive understanding
and intervention among key affected populations. Eco-
nomic migrants represent one such vulnerable popula-
tion that suffer from greater risk of TB and higher
likelihood of poor treatment outcomes. While this study
showed that community-based support can be an appro-
priate response for this vulnerable group, more tailored
research specific to economic migrants is needed to
understand the root causes and develop appropriate pol-
icy responses and protection mechanisms.
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